Uterine Cooling During Cesarean Delivery to Reduce Blood Loss and Incidence of Postpartum Hemorrhage
1 other identifier
interventional
200
1 country
1
Brief Summary
The objective of the study is to demonstrate whether cooling the uterine smooth muscle during cesarean section (following delivery of the fetus) will promote better uterine contraction and involution resulting in lower blood loss, use of fewer uterotonic medications, and fewer hysterectomies following cesarean section. The investigators suspect that it may.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2013
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2014
CompletedFirst Submitted
Initial submission to the registry
August 7, 2014
CompletedFirst Posted
Study publicly available on registry
September 1, 2014
CompletedResults Posted
Study results publicly available
January 13, 2016
CompletedJanuary 19, 2018
December 1, 2015
1.1 years
August 7, 2014
October 28, 2015
January 17, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Blood Loss
At the conclusion of the surgery, blood loss will be calculated by measuring the content of blood in the suction canister, and by weighing the surgical sponges. The amount of blood loss in the PACU will be measured by weighing pads.
During surgery and in the PACU (approximately 3 total hours)
Secondary Outcomes (11)
Change in Pre- vs Post-operative Hematocrit
48 hours post operative period
Use of Uterotonic Medications
During surgery and in the PACU (approximately 3 total hours)
Use of Extra Oxytocin
Intraoperatively
Use of Methergine
Intraoperatively
Use of Hemabate
Intraoperatively
- +6 more secondary outcomes
Other Outcomes (3)
Patient Temperature
Pre-op, Intra-op, Post-Op
Total Time Uterus Wrapped
During hysterotomy repair
Uterine Temperature After Wrap Removed
Immediately following hysterotomy repair
Study Arms (2)
Control
NO INTERVENTIONNormal cesarean technique.
Uterine Cooling
EXPERIMENTALImmediately following delivery of the fetus the uterus will be externalized in the usual fashion and the body of the uterus cephalad to the hysterotomy incision will be wrapped in sterile surgical towels saturated in sterile, iced normal saline. These towels will come from a sterile cooling pot set to 30 degrees Fahrenheit. Iced saline-soaked towels will be kept in place for a minimum of 5 minutes and replaced at the discretion of the attending obstetrician until the hysterotomy is closed and the uterus is replaced into the patient's abdomen.
Interventions
Immediately following delivery of the fetus the uterus will be externalized in the usual fashion and the body of the uterus cephalad to the hysterotomy incision will be wrapped in sterile surgical towels saturated in sterile, iced normal saline. These towels will come from a sterile cooling pot set to 30 degrees Fahrenheit. Iced saline-soaked towels will be kept in place for a minimum of 5 minutes and replaced at the discretion of the attending obstetrician until the hysterotomy is closed and the uterus is replaced into the patient's abdomen.
Eligibility Criteria
You may qualify if:
- Pregnant adult women of any gravidity, and gestational duration who present for cesarean section at Baylor University Medical Center in Dallas and who have given informed consent to be in the study.
You may not qualify if:
- Women who refuse to be in the study, and women who are unable to consent due to emergent nature of the cesarean section will be excluded. Women who are unable to understand the nature of the study due to mental illness, mental retardation, medical condition, or other communication barrier will be excluded.
- Inability to exteriorize the uterus during c-section.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Baylor University Medical Center
Dallas, Texas, 75246, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Janice Mitchell, PI
- Organization
- Baylor University Medical Center
Study Officials
- PRINCIPAL INVESTIGATOR
Janice L Mitchell, MD
Baylor University Medical Center Resident
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 7, 2014
First Posted
September 1, 2014
Study Start
July 1, 2013
Primary Completion
August 1, 2014
Study Completion
August 1, 2014
Last Updated
January 19, 2018
Results First Posted
January 13, 2016
Record last verified: 2015-12